Acurx Pharmaceuticals (ACXP) SEC Filings & 10K Form $1.86 -0.02 (-1.06%) (As of 11/1/2024 ET) Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Recent Acurx Pharmaceuticals SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView08/09/20246:13 AMAcurx Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/15/20246:13 AMAcurx Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/14/20243:05 PMAcurx Pharmaceuticals (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 04/03/20248:55 PMAcurx Pharmaceuticals (Issuer)DELUCCIA ROBERT J (Reporting)Form 4Statement of changes in beneficial ownership of securities 04/03/20248:56 PMAcurx Pharmaceuticals (Issuer)Shawah Robert G. (Reporting)Form 4Statement of changes in beneficial ownership of securities 04/03/20248:56 PMAcurx Pharmaceuticals (Issuer)LUCI DAVID P (Reporting)Form 4Statement of changes in beneficial ownership of securities 04/02/20246:31 AMAcurx Pharmaceuticals (Subject)Form FWP03/29/20243:58 PMAcurx Pharmaceuticals (Filer)Form S-1/A03/15/20243:33 PMAcurx Pharmaceuticals (Filer)Form S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans 02/14/20241:39 PMAcurx Pharmaceuticals (Subject)ARMISTICE CAPITAL, LLC (Filed by)Form SC 13G/A01/22/20245:15 AMAcurx Pharmaceuticals (Issuer)Sailer Carl (Reporting)Form 4Statement of changes in beneficial ownership of securities 01/04/20243:24 PMAcurx Pharmaceuticals (Issuer)LUCI DAVID P (Reporting)Form 4Statement of changes in beneficial ownership of securities 11/15/20233:49 PMAcurx Pharmaceuticals (Filer)Form 424B511/14/20233:05 PMAcurx Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies Galmed Pharmaceuticals 10Q Form Aytu BioPharma 10Q Form Indaptus Therapeutics 10Q Form Eliem Therapeutics 10Q Form Aclaris Therapeutics 10Q Form INmune Bio 10Q Form 23andMe 10Q Form PDS Biotechnology 10Q Form Werewolf Therapeutics 10Q Form Leap Therapeutics 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:ACXP) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acurx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acurx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
